Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In DMC Global (BOOM) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in DMC Global Inc. between January 29, 2024 - November 4, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648 NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recogni ...

NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Olo Inc. (NYSE: OLO), its board of directors, its executive officers, and founder and current CEO Noah H. Glass for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of Olo to Thoma Bravo Discover Fund IV, L.P. (“Thoma Bravo”) for $10.25 per share. If you are a current shareholder of Olo, you are encouraged to obtain additional info ...

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Strategy Incorporated (NASDAQ:MSTR) due to a class action complaint alleging breaches of fiduciary duties by the board of directors during the specified class period [1][2]. Group 1: Legal Investigation - The law firm is encouraging long-term stockholders of Strategy who suffered losses between April 30, 2024, and April 4, 2025, to discuss their legal rights [1]. - A class action complaint was filed on May 16, 2025, concerning the alleged misleading statements made by the company's management regarding its business and operations [2]. Group 2: Allegations Against Management - The complaint claims that the anticipated profitability of Strategy's bitcoin-focused investment strategy was overstated [2]. - It is alleged that the risks associated with bitcoin's volatility and potential losses on digital assets were understated, leading to materially false and misleading public statements [2]. Group 3: Contact Information - Long-term stockholders with information or questions regarding the claims can contact the law firm directly via phone or email [3][6].

It appears LQR House (YHC) is facing a lawsuit from 'Kingbird Ventures LLC' filed as of July 11The suit alleges that Sean Dollinger and the board of directors have breached fiduciary duties amongst other allegations and seeks injunctive relief preventing them from making any other corporate decision (i.e. issuing more stock shares).LQR House filed a form 8-K with the SEC disclosing the suit today, sharing their intent to fight back.The plot thickens... ...

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against DMC Global Inc. due to allegations of securities laws violations and breaches of fiduciary duties related to misleading statements and inadequate internal systems [1][2]. Group 1: Investigation Details - The investigation focuses on whether DMC Global's board of directors breached their fiduciary duties to the company [1]. - Allegations include that the goodwill associated with DMC Global's principal business segment, Acadia Products, was overstated due to adverse events affecting that segment [2]. - It is claimed that DMC Global's internal systems and processes were materially inadequate, adversely affecting its operations and public disclosures [2]. Group 2: Legal Rights and Contact Information - Long-term stockholders of DMC Global are encouraged to contact Bragar Eagel & Squire for more information regarding their rights and the ongoing investigation [3]. - The law firm offers no cost or obligation for stockholders seeking to learn more about the claims [3]. Group 3: About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across state and federal courts [4].

Core Viewpoint - Bleichmar Fonti & Auld LLP is investigating Olo Inc. and its leadership for potential breaches of fiduciary duties related to the company's pending acquisition by Thoma Bravo at a price of $10.25 per share, which values Olo at approximately $2 billion in equity [1][3][4]. Company Overview - Olo Inc. operates an open SaaS platform designed for restaurants, facilitating digital commerce operations such as ordering, delivery, engagement, and payments [3]. - The company's stock is divided into Class A and Class B shares, with Class B shares having ten votes per share compared to one vote for Class A shares. As of December 31, 2024, directors and executive officers collectively owned about 82% of the voting power of Olo's outstanding capital stock [3]. Acquisition Details - On July 3, 2025, Olo announced a definitive agreement to be acquired by Thoma Bravo in an all-cash transaction, with shareholders set to receive $10.25 per share [3]. - The purchase price represents a 65% premium over Olo's unaffected share price of $6.20 as of April 30, 2025 [3]. Legal Investigation - The investigation by BFA Law focuses on whether Olo's board of directors, executive officers, and CEO Noah H. Glass acted in the best interests of shareholders during the merger process [4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against West Pharmaceutical Services, Inc. due to allegations of fiduciary duty breaches by the board of directors following a class action complaint filed on June 20, 2025 [1] Company Overview - West Pharmaceutical Services, Inc. is a medical supplies company based in Exton, Pennsylvania, serving as a key supplier to the pharmaceutical, biotechnology, and generic drug industries [2] Allegations and Issues - The class action complaint alleges that West failed to disclose significant destocking issues in its high-margin High-Value Products portfolio, despite claiming strong visibility into customer demand [2] - The SmartDose device, positioned as a high-margin growth product, was found to be dilutive to profit margins due to operational inefficiencies [2] - Margin pressures raised the risk of costly restructuring activities, including the exit from continuous glucose monitoring contracts with long-standing customers [2] - Positive statements made by the company regarding its business and prospects were claimed to be materially false or misleading [2] Disclosure of Financial Issues - The truth about the alleged fraud was revealed on February 13, 2025, when West issued weak revenue and earnings forecasts for 2025, attributing the disappointing guidance to contract manufacturing headwinds and the loss of two major customers [3] - West indicated that its SmartDose devices would be margin-dilutive in 2025 and mentioned plans to improve the device's economics [3] - Following this disclosure, West's stock price dropped by $123.17 per share, a decline of 38%, closing at $199.11 on February 13, 2025 [3]

Group 1 - Halper Sadeh LLC is investigating TuHURA Biosciences, Inc. (NASDAQ: HURA) for potential violations related to its merger with Kineta, Inc. [1] - Vigil Neuroscience, Inc. (NASDAQ: VIGL) is under scrutiny due to its sale to Sanofi, where shareholders will receive $8.00 per share in cash and a contingent value right for an additional $2.00 per share based on the commercial sale of VG-3927 [1] - The firm may seek increased consideration for shareholders and additional disclosures regarding the proposed transactions [2] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no cost [3] - The firm represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [3]

Core Viewpoint - The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Harley-Davidson, Inc. regarding possible breaches of fiduciary duties to shareholders and allegations of gross mismanagement of the company [1]. Group 1 - The investigation focuses on whether the board of directors of Harley-Davidson has acted in the best interests of shareholders [1]. - Shareholders are encouraged to participate in the investigation if they hold shares in Harley-Davidson [1]. Group 2 - The Law Offices of Frank R. Cruz provides contact information for shareholders who wish to discuss their rights and interests related to the investigation [3].

Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into CareDx, Inc. for potential breaches of fiduciary duties and violations of federal securities laws [1][2]. Investigation Details - The investigation focuses on actions taken by CareDx insiders between April 30, 2020, and February 24, 2022, which involved issuing false and misleading statements about the company's compliance with healthcare laws and revenue growth [2]. - CareDx began disclosing issues on October 28, 2021, revealing that the company was under multiple government investigations and that its financial results were significantly lower than previously reported [2]. - By November 3, 2022, CareDx's share price had decreased by over 77.22% from its previous levels [2]. Shareholder Information - Current stockholders who have held CareDx stock since at least January 2021 are encouraged to contact Johnson Fistel to discuss their legal rights regarding the investigation [3].